Tumor necrosis factor-α, interleukin-1β, and interleukin-1 receptor antagonist in dialysate and serum from patients on continuous ambulatory peritoneal dialysis

American Journal of Kidney Diseases

Volumn 27, Issue 3, 1996, Pages 402-408

  Brauner, A ^a   Hylander, B ^a   Wretlind, B ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Continuous ambulatory peritoneal dialysis; interleukin 1 receptor antagonist; interleukin 1 ; peritonitis; tumor necrosis factor

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD LEVEL; FEMALE; HUMAN; IMMUNE RESPONSE; INFECTION RISK; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PERITONITIS;

EID: 0029868544     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(96)90364-9     Document Type: Article

References (24)

1. N Topley R Mackenzie A Jörres GA Coles M Davies JD Williams Cytokine networks in continuous ambulatory peritoneal dialysis: Interactions of resident cells during inflammation in the peritoneal cavity Perit Dial Int 13 suppl 2 1993 S282 S285
2. J Le J Vilcek Biology of disease Tumor necrosis factor and interleukin 1: Cytokines with multiple overlapping biological activities ed 2 Lab Invest 56 1987 234 248
3. Y Fong KJ Tracey LL Moldawer DG Hesse KB Manogue JS Kenney AT Lee GC Kuo AC Allison SF Lowry A Cerami Antibodies to cachectin/tumor necrosis factor reduce interleukin 1β and interleukin 6 appearance during lethal bacteremia J Exp Med 170 1989 1627 1633
4. HR Alexander BC Sheppard JC Jensen HN Langstein CM Buresh D Venzon EC Walker DL Fraker MC Stovroff JA Norton Treatment with recombinant human tumor necrosis factor-alpha protects rats against lethality, hypotension, and hypothermia of Gram-negative sepsis J Clin Invest 88 1991 34 39
5. CA Dinarello Interleukin 1 and interleukin 1 antagonism Blood 77 1991 1627 1652
6. G Wakabayashi JA Gelfand JF Burke RC Thompson CA Dinarello A specific receptor antagonist for interleukin-1 prevents Escherichia coli -induced shock in rabbits FASEB J 5 1991 338 343
7. A Brauner M Leissner B Wretlind I Julander SB Svenson G Källenius Occurrence of P-fimbriated E. coli in patients with bacteremia Eur J Clin Microbiol 4 1985 566 569
8. CA Dinarello The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic schock syndrome J Infect Dis 163 1991 1177 1184
9. MGH Betjes CW Tuk DG Struijk RT Krediet L Arisz M Hart RHJ Beelen Interleukin-8 production by human peritoneal mesothelial cells in response to tumor necrosis factor-α, interleukin-1, and medium conditioned by macrophages cocultured with Staphylococcus epidermidis J Infect Dis 168 1993 1202 1210
10. A Brauner B Hylander B Wretlind Interleukin-6 and interleukin-8 in dialysate and serum from patients on continuous ambulatory peritoneal dialysis Am J Kidney Dis 22 1993 430 435
11. GJ Bagby KJ Plessala LA Wilson JJ Thompson S Nelson Divergent efficacy of antibody to tumor necrosis factor-α in intravascular and peritonitis models of sepsis J Infect Dis 163 1991 83 88
12. A Zumla Superantigens, T cells, and microbes Clin Infect Dis 15 1992 313 320
13. MWJA Fieren GJCM van den Bemd IL Bonta S Ben-Efraim Peritoneal macrophages from patients on continuous ambulatory peritoneal dialysis have an increased capability to release tumor necrosis factor during peritonitis J Clin Lab Immunol 34 1991 1 9
14. R Schindler J Mancilla S Endres R Ghorbani SC Clark CA Dinarello Correlations and interactions in the production of interleukin-6 (IL-6), IL-1 and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF Blood 75 1990 40 47
15. PR Young DJ Hazuda PL Simon Human interleukin 1 beta is not secreted from hamster fibroblasts when expressed constitutively from transfected cDNA J Cell Biol 107 1988 447 456
16. PH Hart KL Jones JJ Finlay-Jones Reduced secretion of IL-1β by peritoneal cells from patients on continuous ambulatory peritoneal dialysis Immunol Cell Biol 71 1993 99 107
17. P Seckinger JW Lowenthal K Williamson J-M Dayer HR MacDonald A urine inhibitor of interleukin 1 activity that blocks ligand binding J Immunol 139 1987 1546 1549
18. FT Stevenson RM Locksley DH Lovett The extracellular cytokine, interleukin-1, is synthesized on free polyribosomes and distributed intracellularly as a cytoskeletal-associated protein Clin Res 39 1991 290A
19. J Andersson S Nagy L Björk J Abrams S Holm U Andersson Bacterial toxin-induced cytokine production studied at the single-cell level Immunol Rev 127 1992 69 96
20. WP Arend Interleukin 1 receptor antagonist A new member of the interleukin 1 family ed 2 J Clin Invest 88 1991 1445 1451
21. JW Dobbie JK Lloyd CA Gall Categorization of ultrastructural changes in peritoneal mesothelium, stroma, and blood vessels in uremia and CAPD patients R Khanna KD Nolph B Prowant ZJ Twardowski DG Oreopoulos Advances in Peritoneal Dialysis 1990 University of Toronto Press Toronto, Canada 3 12
22. M Friedlander Peritoneal function and peritonitis in patients on peritoneal dialysis J Lab Clin Med 122 1993 639 640
23. D Zemel GCM Koomen AAM Hart IJM ten Berge DG Struijk RT Krediet Relationship of TNF-α, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis J Lab Clin Med 122 1993 686 696
24. B Echtenacher W Falk DN Männel PH Krammer Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis J Immunol 145 1990 3762 3766